Trial intelligence / Profile preview

Perioperative Neupro treatment in idiopathic Parkinson's disease

2006-005438-19Phase 4Completed

Sponsor
Schwarz Pharma
Start
Mar 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of rotigotine in Parkinson's disease (PD), sponsored by Schwarz Pharma. Primary endpoint: Feasibility assessment questionnaire by the anesthesiologist. Started Mar 2007; status: completed.

02

Drugs

rotigotine
03

Conditions

Parkinson's disease (PD)

Beyond the preview

Go deeper on 2006-005438-19.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-005438-19.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call